A Comprehensive Study on Aptasensors For Cancer Diagnosis

Author(s): Sambhavi Animesh, Yengkhom D. Singh*

Journal Name: Current Pharmaceutical Biotechnology

Volume 22 , Issue 8 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Cancer is the most devastating disease in the present scenario, killing millions of people every year. Early detection, accurate diagnosis, and timely treatment are considered to be the most effective ways to control this disease. Rapid and efficient detection of cancer at their earliest stage is one of the most significant challenges in cancer detection and cure. Numerous diagnostic modules have been developed to detect cancer cells early. As nucleic acid equivalent to antibodies, aptamers emerge as a new class of molecular probes that can identify cancer-related biomarkers or circulating rare cancer/ tumor cells with very high specificity and sensitivity. The amalgamation of aptamers with the biosensing platforms gave birth to "Aptasensors." The advent of highly sensitive aptasensors has opened up many new promising point-of-care diagnostics for cancer. This comprehensive review focuses on the newly developed aptasensors for cancer diagnostics.

Keywords: Aptamers, cancer diagnosis, biomarker, aptasensors, cancer, therapy.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 22
ISSUE: 8
Year: 2021
Published on: 14 June, 2021
Page: [1069 - 1084]
Pages: 16
DOI: 10.2174/1389201021999200918152721
Price: $65

Article Metrics

PDF: 19